Transgender hormone therapy (female-to-male) to individuals taking bioidentical hormones in the form of testosterone (including esters) and do not apply to those taking synthetic AAS (e.g., nandrolone) or dihydrotestosterone. Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people
Sexual arousal role in determining how a person will respond in any given sexual situation. On the other hand, a person may be hypersexual, which is a desire to engage in sexual activities considered abnormally high in relation to normal development or culture, or suffering from a persistent genital arousal disorder, which is a spontaneous, persistent, and uncontrollable arousal, and the physiological changes associated with arousal. Sexual arousal causes various physical responses, most significantly in the sex organs (genital organs). Sexual arousal for a man is usually indicated by the swelling and erection of the penis when blood fills the corpus cavernosum.